SensiVida Medical Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

SensiVida Medical Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between SensiVida Medical Technologies, Inc. and its competitors. This provides our Clients with a clear understanding of SensiVida Medical Technologies, Inc. position in the Pharmaceuticals and Biotechnology Industry.

• The report contains detailed information about SensiVida Medical Technologies, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• Another part of the report is a SWOT-analysis carried out for SensiVida Medical Technologies, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
• The SensiVida Medical Technologies, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
• In the part that describes SensiVida Medical Technologies, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of SensiVida Medical Technologies, Inc. business.

About SensiVida Medical Technologies, Inc.

SensiVida Medical Technologies, Inc., a minimally invasive bio-medical diagnostic device company, engages in the design and development of medical diagnostic instruments.

The company’s medical diagnostic instruments detect cancer in vivo in humans by using light to excite the molecules contained in tissue and measuring the differences in the resulting natural fluorescence between cancerous and normal tissue.

The company’s proprietary optical Micro-systems based technology automates bio-sensing and data acquisition while minimizing patient discomfort. Its platform technology addresses a range of disease state diagnostics, including allergy testing, pain-free automated glucose monitoring without bio-fouling, blood coagulation testing (for Coumadin patients), Tuberculosis (TB) testing, and cholesterol monitoring.

Products

Allergy Test Systems

The SensiVida Allergy Test system offers the allergist, painless allergy testing system that consists of the following: A disposable microlancet chip/cartridge that painlessly and rapidly administers the allergens; Imaging module/digital imager that captures real-time allergic reactions and sends images and data wirelessly or via a USB interface to a computer; and Software that allows the user to monitor the allergic reaction that provides quantitative data regarding reaction extent, positive/negative diagnosis versus allergen, and reaction kinetics. An e-record patient report is automatically created which can be printed or transmitted.

Glucose Monitoring System

The SensiVida product family consists of an unobtrusive, wearable glucose monitoring system with a disposable microlancet chip having individually-monitored sensors that are actuated in accordance to the patient's test schedule. It provides a positive Value Proposition for various customer segments in the value chain, including health care facilities, hospitals, and patients.

Molecular Optical Biopsy Technology

The Sensivida's product family plan includes its Photonic Pill, designed with the merging of optical imaging techniques (fluorescent light, excited photonic light, and varying spectroscopy techniques) and micro-technology scaling attributes and capabilities. Such MEMS devices use three-dimensional mechanical components of various configurations on a miniaturized scale, including an optical component, resulting in a Molecular Optical Biopsy pill system.

Competition

The company’s competitors include Medtronics, Dexcom, Abbott, Animas, In Light solutions, NIR Diagnostics, SenSys Medical, RetiTech, Spect Rx, Visual Pathways, Ciba/University of Maryland, Glucowatch, Spec Rx, and Kumetrix.

History

SensiVida Medical Technologies, Inc. was founded in 1971.